Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

Delayed Data
As of 3:59pm ET
 -1.05 / -3.03%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 47.50, with a high estimate of 60.00 and a low estimate of 31.00. The median estimate represents a +41.12% increase from the last price of 33.66.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -12.31%
Growthannually -18.25%


Growthquarterly 26.40%
Growthannually 420.39%
Key to the earnings and sales forecast charts.